Vinflunine: a novel antitubulin agent in solid malignancies

Author： Bennouna Jaafar   Campone Mario   Delord Jean Pierre   Pinel Marie-Claire  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.10, 2005-10, pp. : 1259-1267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vinflunine

By Frampton James E.   Moen Marit D.  

Drugs, Vol. 70, Iss. 10, 2010-07 ,pp. : 1283-1293

Adis International

Access to resources Recommend Favorite

Novel dual Src/Abl inhibitors for hematologic and solid malignancies

By Schenone Silvia   Brullo Chiara   Musumeci Francesca   Botta Maurizio  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 931-945

Informa Healthcare

Access to resources Recommend Favorite

Phase I trial of vinflunine and pemetrexed in refractory solid tumors

By Sanoff Hanna   Davies Janine   Walko Christine   Buie Larry   Chiu Wing-Keung   Ivanova Anastasia   O’Neil Bert   Stinchcombe Thomas   Keller Kimberly   Dees E.  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 131-136

Springer Publishing Company

Access to resources Recommend Favorite

Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid

By Schutz Fabio AB   Bellmunt Joaquim   Rosenberg Jonathan E   Choueiri Toni K  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 645-653

Informa Healthcare

Access to resources Recommend Favorite

Novel Immunotherapies for Hematological Malignancies

By  

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-09 ,pp. : 264-271

Bentham Science Publishers

Access to resources Recommend Favorite